SPONTANEOUS PLATELET ACTIVATION IN-VIVO AS A CAUSE OF PLATELET-MEDIATED THROMBOSIS IN THROMBOCYTHEMIA - RATIONALE FOR USING LOW-DOSE ASPIRIN AS A SAFE AND EFFECTIVE ANTITHROMBOTIC AGENT
Jj. Michiels et al., SPONTANEOUS PLATELET ACTIVATION IN-VIVO AS A CAUSE OF PLATELET-MEDIATED THROMBOSIS IN THROMBOCYTHEMIA - RATIONALE FOR USING LOW-DOSE ASPIRIN AS A SAFE AND EFFECTIVE ANTITHROMBOTIC AGENT, British Journal of Haematology, 102(1), 1998, pp. 359-359